Skip to main content

Table 1 Inclusion and non-inclusion criteria for the clinical trial: MSC treatment of vocal fold scarring

From: Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells—first phase I/II human clinical study

Inclusion criteria
 Severe hoarseness, vocal fatigue
 Vocal fold scarring
 No active other treatment
 Age above 18 years
Exclusion criteria
 Active treatment of laryngeal disorder
 Active inflammatory condition of the larynx or laryngeal papilloma
 Diagnosed or suspicions of local malignancy
 No female patient was pregnant and all patients were negative for HIV, HBV, HCV, HTLV, syphilis, and lues